
As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s purchases of Serum Institute of India and Bharat Biotech’s vaccines were “overpriced”.
Comments
Post a Comment